ARCHIVES

Gene Variant Associated With 44 Percent Cancer Risk Reduction

This article is from The Cancer Letter archive.

Vol. 35 No. 10 | October 26, 2012

Download PDF Visit The Full Archive

Related Articles

Other DCT Concepts Approved By Board

February 26, 1988

In Brief: Breast Cancer Cells To Be Studied In Space; GrieshaberTo Head Drug Discovery Program

January 30, 1998

FDA Committee Agenda Includes M-AMSA, THC, Estramustine, Platinum

May 22, 1981

FDA, ASCO Meet to Review Drug Approval Endpoints

April 25, 2003

DRCCA Board Again Approves Breast Cancer Dietary Study

May 13, 1983

Arthur James, Ohio Founder Of Research Institute, Dead.

October 26, 2001